Daniel C Batlle, MD
Disclosures: Consulting Fee-current -Relypsa|Consulting Fee-Current-Tricida|Grant support-Current-AstraZeneca|Receipt of Intellectual Property Rights/Patent Holder-Co-inventor of 3 patents that Northwestern University has licensed to Angiotensin Therapeutics Inc. The names of the patents are: “Active Low Molecular Weight Variants of Angiotensin Converting Enzyme 2”, “Active low molecular weight variants of Angiotensin Converting Enzyme 2 (ACE2) for the treatment of diseases and conditions of the eye” and “Shorter soluble forms of Angiotensin Converting Enzyme 2 (ACE2) for treating and preventing coronavirus infection.”-Angiotensin Therapeutics Inc.
No Bio Available.